TickerFactsScreenerDevelopers

Axsome Therapeutics, Inc. (AXSM) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2014: -$4.60M2015: -$7.44M2016: -$21.28M2017: -$26.47M2018: -$30.05M2019: -$46.38M2020: -$78.46M2021: -$108.23M2022: -$116.51M2023: -$145.08M2024: -$128.41M2025: -$93.41M-$93.41M
2014Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$93.41M+27.3%
2024-$128.41M+11.5%
2023-$145.08M-24.5%
2022-$116.51M-7.7%
2021-$108.23M-37.9%
2020-$78.46M-69.2%
2019-$46.38M-54.3%
2018-$30.05M-13.5%
2017-$26.47M-24.4%
2016-$21.28M-186.1%
2015-$7.44M-61.8%
2014-$4.60M—